Literature DB >> 14684152

S100A16, a ubiquitously expressed EF-hand protein which is up-regulated in tumors.

Ingo Marenholz1, Claus W Heizmann.   

Abstract

Calcium binding proteins of the S100 family play a central role in many intra- and extracellular processes and abnormal expression was observed in various tumors and human diseases. We have identified a unique new member of this gene family: S100A16 which is the S100 protein widest distributed in human and which is highly conserved in mammals. Up-regulation of S100A16 was found in many tumors implying a central cellular function related to malignant transformation. The gene was composed of four exons, two of which alternatively initiated transcription. Three different transcripts suggested a complex regulation of the S100A16 gene. Moreover, CAG repeats were identified in the transcribed region which might be associated with diseases of the nervous system. All human transcripts encoded the same, typically small S100 protein of 103 amino acids containing the S100-specific motif of two distinct EF-hands. S100A16 was mapped within the S100 gene cluster on human chromosome 1q21, a region that is frequently rearranged in tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14684152     DOI: 10.1016/j.bbrc.2003.11.115

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  Differential gene expression of S100 protein family in leukocytes from patients with Kawasaki disease.

Authors:  Takashi Ebihara; Rika Endo; Hideaki Kikuta; Nobuhisa Ishiguro; Xiaoming Ma; Mitsunobu Shimazu; Takao Otoguro; Kunihiko Kobayashi
Journal:  Eur J Pediatr       Date:  2005-04-19       Impact factor: 3.183

2.  Structural characterization of human S100A16, a low-affinity calcium binder.

Authors:  Elena Babini; Ivano Bertini; Valentina Borsi; Vito Calderone; Xiaoyu Hu; Claudio Luchinat; Giacomo Parigi
Journal:  J Biol Inorg Chem       Date:  2010-11-03       Impact factor: 3.358

3.  S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.

Authors:  Weidong Zhu; Yi Xue; Chao Liang; Rihua Zhang; Zhihong Zhang; Hongyan Li; Dongming Su; Xiubin Liang; Yuanyuan Zhang; Qiong Huang; Menglan Liu; Lu Li; Dong Li; Allan Z Zhao; Yun Liu
Journal:  Tumour Biol       Date:  2016-05-30

4.  Interference of S100A16 suppresses lipid accumulation and inflammation in high glucose-induced HK-2 cells.

Authors:  Lanlan Liu; Shan Lan
Journal:  Int Urol Nephrol       Date:  2021-01-03       Impact factor: 2.370

5.  S100A16 up-regulates Oct4 and Nanog expression in cancer stem-like cells of Yumoto human cervical carcinoma cells.

Authors:  Nariaki Tomiyama; Ryuji Ikeda; Yukihiko Nishizawa; Shogo Masuda; Yusuke Tajitsu; Yasuo Takeda
Journal:  Oncol Lett       Date:  2018-04-25       Impact factor: 2.967

6.  Integrated analysis identifies S100A16 as a potential prognostic marker for pancreatic cancer.

Authors:  Tian Chen; De-Meng Xia; Chao Qian; Shan-Rong Liu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

7.  Physiological stress induces the metastasis marker AGR2 in breast cancer cells.

Authors:  Daniel R Zweitzig; Denis A Smirnov; Mark C Connelly; Leon W M M Terstappen; S Mark O'Hara; Elizabeth Moran
Journal:  Mol Cell Biochem       Date:  2007-08-11       Impact factor: 3.396

8.  S100A14 interacts with S100A16 and regulates its expression in human cancer cells.

Authors:  Dipak Sapkota; Daniela Elena Costea; Salah O Ibrahim; Anne C Johannessen; Ove Bruland
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

Review 9.  S100 protein family in human cancer.

Authors:  Hongyan Chen; Chengshan Xu; Qing'e Jin; Zhihua Liu
Journal:  Am J Cancer Res       Date:  2014-03-01       Impact factor: 6.166

10.  S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways.

Authors:  Dan Fang; Chengfei Zhang; Ping Xu; Yinhua Liu; Xiao Mo; Qi Sun; Alaa Abdelatty; Chao Hu; Haojun Xu; Guoren Zhou; Hongping Xia; Linhua Lan
Journal:  Cell Biol Toxicol       Date:  2021-01-02       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.